{"id":52979,"date":"2023-01-17T14:02:53","date_gmt":"2023-01-17T13:02:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/"},"modified":"2023-01-17T14:02:53","modified_gmt":"2023-01-17T13:02:53","slug":"incyte-to-report-fourth-quarter-and-year-end-2022-financial-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/","title":{"rendered":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results"},"content":{"rendered":"<div>\n<p>WILMINGTON, Del.&#8211;(BUSINESS WIRE)&#8211;Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/5\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\"><\/a><\/p>\n<p>\nThe schedule for the press release and conference call\/webcast is as follows:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nQ4 &amp; YE 2022 Press Release: February 7, 2023 at 7:00 a.m. ET\n<\/li>\n<li>\nQ4 &amp; YE 2022 Conference Call: February 7, 2023 at 8:00 a.m. ET\n<\/li>\n<li>\nDomestic Dial-In Number: 877-407-3042\n<\/li>\n<li>\nInternational Dial-In Number: 201-389-0864\n<\/li>\n<li>\nConference ID Number: 13735569\n<\/li>\n<\/ul>\n<p>\nIf you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415<b>.<\/b> To access the replay you will need the conference ID number 13735569.\n<\/p>\n<p>\nThe live webcast with slides can be accessed at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.incyte.com%2F&amp;esheet=53214945&amp;newsitemid=20230117005125&amp;lan=en-US&amp;anchor=Investor.Incyte.com&amp;index=1&amp;md5=665c4294bcab9c77081c8fec4e02ef14\" rel=\"nofollow noopener\" shape=\"rect\">Investor.Incyte.com<\/a> and will be available for replay for 90 days.\n<\/p>\n<p>\n<b>About Incyte\u00a0<br \/>\n<br \/><\/b>Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.incyte.com%2F&amp;esheet=53214945&amp;newsitemid=20230117005125&amp;lan=en-US&amp;anchor=Incyte.com&amp;index=2&amp;md5=e7d3dcf88c2722f1200837d7959e8d23\" rel=\"nofollow noopener\" shape=\"rect\">Incyte.com<\/a> and follow <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FIncyte&amp;esheet=53214945&amp;newsitemid=20230117005125&amp;lan=en-US&amp;anchor=%40Incyte&amp;index=3&amp;md5=32eeb6ffa499b8466da86d1f27d00c76\" rel=\"nofollow noopener\" shape=\"rect\">@Incyte<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b><span class=\"bwuline\">Incyte Contacts<\/span><\/b><br \/><b>Media<\/b><br \/>Catalina Loveman<br \/>\n<br \/>+1 302 498 6171<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#99;&#x6c;o&#118;&#x65;m&#97;&#x6e;&#x40;&#105;&#x6e;&#x63;y&#116;&#x65;&#46;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#108;o&#x76;&#101;m&#x61;&#110;&#64;&#x69;&#x6e;&#99;&#x79;&#x74;&#101;&#46;&#x63;&#111;m<\/a>\n<\/p>\n<p>\n<b>Investors<\/b><br \/>Christine Chiou<br \/>\n<br \/>+1 302 274 4773<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#x3a;&#99;&#x63;&#x68;&#105;&#x6f;&#x75;&#64;&#x69;&#x6e;c&#x79;&#116;e&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x63;&#99;h&#x69;&#111;u&#x40;&#105;n&#x63;&#121;t&#x65;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>WILMINGTON, Del.&#8211;(BUSINESS WIRE)&#8211;Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023. The schedule for the press release and conference call\/webcast is as follows: Q4 &amp; YE 2022 Press Release: February 7, 2023 at 7:00 a.m. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-52979","format-standard","category-industry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WILMINGTON, Del.&#8211;(BUSINESS WIRE)&#8211;Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023. The schedule for the press release and conference call\/webcast is as follows: Q4 &amp; YE 2022 Press Release: February 7, 2023 at 7:00 a.m. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-17T13:02:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results\",\"datePublished\":\"2023-01-17T13:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/\"},\"wordCount\":212,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005125\\\/en\\\/1078784\\\/21\\\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/\",\"name\":\"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005125\\\/en\\\/1078784\\\/21\\\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\",\"datePublished\":\"2023-01-17T13:02:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005125\\\/en\\\/1078784\\\/21\\\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230117005125\\\/en\\\/1078784\\\/21\\\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend","og_description":"WILMINGTON, Del.&#8211;(BUSINESS WIRE)&#8211;Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023. The schedule for the press release and conference call\/webcast is as follows: Q4 &amp; YE 2022 Press Release: February 7, 2023 at 7:00 a.m. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-17T13:02:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results","datePublished":"2023-01-17T13:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/"},"wordCount":212,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/","url":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/","name":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg","datePublished":"2023-01-17T13:02:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230117005125\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/incyte-to-report-fourth-quarter-and-year-end-2022-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Incyte to Report Fourth Quarter and Year-End 2022 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52979"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52979\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}